Tuberous sclerosis complex is a multisystem autosomal dominant genetic disorder resulting from mutations in one of two genes, TSC1 and TSC2. Pathologically, tuberous sclerosis complex is characterized by abnormal cellular differentiation and proliferation, as well as abnormal neuronal migration. Epilepsy occurs in about 90% of patients, with onset frequently in the first year of life. In a sizable proportion of individuals, seizures tend to be refractory to antiepileptic drug treatment. This article reviews the progress in understanding drug-resistant seizures in tuberous sclerosis complex, from molecular pathogenesis to the pathophysiologic mechanisms of epileptogenesis, and the rationale for appropriate medical and surgical treatment. (J Child Neurol 2005;20:318—325).
Get full access to this article
View all access options for this article.
References
1.
Sarnat H.: Molecular genetic classification of central nervous system malformations. J Child Neurol2000;15:675—687.
2.
Curatolo P., Verdecchia M., Bombardieri R.: Tuberous sclerosis complex: A review of neurological aspects. Eur J PaediatrNeurol2002;6:15—23.
3.
Curatolo P., Cusmai R., Cortesi F., et al: Neurologic and psychiatric aspects of tuberous sclerosis. Ann N Y Acad Sci1991;615:8—16.
4.
Seri S., Cerquiglini A., Pascual Marqui M, et al: Frontal lobe epilepsy: EEG-MRI fusioning. J Child Neurol1998;13:34—38.
5.
Sparagana SP , Delgado MR, Batchelor LL, Roach ES: Seizure remission and antiepileptic drug discontinuation in children with tuberous sclerosis complex. Arch Neurol2003;60:1286—1289.
6.
Curatolo P., Verdecchia M.: Neurological manifestations, in Curatolo P (ed): Tuberous Sclerosis Complex: From Basic Science to Clinical Phenotypes. Cambridge, UK, Cambridge University Press, 2004, 26—45.
7.
Crino PBMolecular neurobiology, in Curatolo P (ed): Tuberous Sclerosis Complex: From Basic Science to Clinical Phenotypes . Cambridge, UK, Cambridge University Press, 2004, 124—135.
8.
Richardson EP : Pathology of tuberous sclerosis. Ann N Y Acad Sci1991;615:128—139.
9.
Roske B., Stoltenburg G., Baier PM, et al: Tuberous sclerosis complex with disseminated telencephalic distribution of atypical cells and their relation to corticogenesis. Clin Neuropathol2003;22:119—128.
10.
Nellist M., van Slegtenhorst MA, Goedbloed M., et al: Characterization of the cytosolic tuberin-hamartin complex. Tuberin is a cytosolic chaperone for hamartin. J Biol Chem1999;274: 35647—35652.
11.
Kwiatkowski D. , Reeve MP, Cheadle JP, Sampson JRMolecular genetics, in Curatolo P (ed): Tuberous Sclerosis Complex: From Basic Science to Clinical Phenotypes. Cambridge, UK, Cambridge University Press, 2004, 228—263.
12.
Dabora SL, Jozwiak S., Franz DN, et al: Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2 compared with TSC1 disease in multiple organs. Am J Hum Genet2001;68:64—80.
13.
Wolf HK, Birkholz T., Wellmer J., et al: Neurochemical profile of glioneuronal lesions from patients with pharmacoresistant focal epilepsies. J Neuropathol Exp Neurol1995;54:689—697.
14.
White R., Hua Y., Scheithauer B., et al: Selective alterations in glutamate and GABA receptor subunit mRNA expression in dysplastic neurons and giant cells of cortical tubers. Ann Neurol2001;49:67—78.
15.
Concas A., Follesa P., Barbaccia ML, et al: Physiological modulation of GABA(A) receptor plasticity by progesterone metabolites. Eur J Pharmacol1999;375:225—235.
16.
Di Michele F, Verdecchia M., Dorofeva M., et al: GABA(A) receptor active steroids are altered in epileptic patients with tuberous sclerosis. J Neurol Neurosurg Psychiatry2003;74:667—670.
17.
Lazarowski A., Lubieniecki F., Camarero S., et al: Multidrug resistance proteins in tuberous sclerosis and refractory epilepsy. Pediatr Neurol2004;30:102—106.
18.
Hancock E., Osborne JP: Vigabatrin in the treatment of infantile spasms in tuberous sclerosis: Literature review. J Child Neurol1999;14:71—74.
19.
Curatolo P. : Vigabatrin for refractory partial seizures in children with tuberous sclerosis. Neuropediatrics1994;25:55—56.
20.
Eke T., Talbot JF, Lawden MC: Severe persistent visual field constriction associated with vigabatrin. BMJ1997;314:180—181.
21.
Tong X., O'Connell MT, Ratnaraj N., Patsalos PN: Vigabatrin and GABA concentration inter-relationship in rat extracellular fluid (EDF) from frontal cortex and hippocampus, abstract. Epilepsia2000;41:95.
22.
Mauri-Llerda JA, Iniguez C., Tejero-Juste C., et al: Visual field changes secondary to vigabatrin treatment. Rev Neurol2000;31:1104—1108.
23.
Duboc A., Hanoteau N., Simonutti M., et al: Vigabatrin, the GABAtransaminase inhibitor, damages cone photoreceptors in rats. Ann Neurol2004;55:695—705.
24.
Franz DN, Tudor C., Leonard J.: Topiramate as therapy for tuberous sclerosis complex-associated seizures, abstract. Epilepsia2000;41:87.
25.
Curatolo P., Seri S.: Seizures, in Curatolo P (ed): Tuberous Sclerosis Complex: From Basic Science to Clinical Phenotypes. Cambridge, UK, Cambridge University Press, 2004 , 46—76.
26.
Asano E., Chugani DC, Chugani HT: Positron emission tomography, in Curatolo P (ed): Tuberous Sclerosis Complex: From Basic Science to Clinical Phenotypes. Cambridge, Cambridge University Press, 2004, 124—135.
27.
Chugani DC, Chugani HT, Muzik O., et al: Imaging epileptogenic tubers in children with tuberous sclerosis complex using alpha-11C-methyl-L-tryptophan positron emission tomography. Ann Neurol1998;44:858—866.
28.
Asano E., Chugani DC, Muzik O., et al: Multimodality imaging for improved detection of epileptogenic foci in tuberous sclerosis complex. Neurology2000;54:1976—1984.
29.
Juhasz C., Chugani DC, Muzik O., et al: Alpha-methyl-L-tryptophan PET detects epileptogenic cortex in children with intractable epilepsy. Neurology2003;60:960—968.
30.
Guerreiro MM , Andermann F., Andermann E., et al: Surgical treatment of epilepsy in tuberous sclerosis: Strategies and results in 18 patients. Neurology1998;51:1263—1269.
31.
Palmini A., Andermann F., Olivier A., et al: Focal neuronal migration disorders and intractable partial epilepsy: Results of surgical treatment. Ann Neurol1991;30:750—757.
32.
Wennenberg R., Quesney LF, Lozano A., et al: Role of electrocorticography at surgery for lesion-related frontal lobe epilepsy. Can J Neurol Sci1999;26:33—39.
33.
Romanelli P. , Weiner HL, Najjar S., Devinsky O.: Bilateral resective epilepsy surgery in a child with tuberous sclerosis: Case report. Neurosurgery2001;49:732—744.
34.
Romanelli P. , Naijar S., Weiner HL, Devinsky O.: Epilepsy surgery in tuberous sclerosis: Multistage procedures with bilateral or multilobar foci. J Child Neurol2002;17:689—692.
35.
Baumgartner JE, Wheless JW, Kulkarni S., et al: On the surgical treatment of refractory epilepsy in tuberous sclerosis complex. Pediatr Neurosurg1997;27:311—318.
36.
Bye AM, Matheson JM, Tobias VH, et al: Selective epilepsy surgery in tuberous sclerosis. Aust Paediatr J1989;25:243—245.
37.
Erba G., Duchowny MS: Partial epilepsy and tuberous sclerosis: Indication for surgery in disseminated disease. J Epilepsy1990;3:315—319.
38.
Sinclair DB , Aronyk K., Snyder T., et al: Pediatric temporal lobectomy for epilepsy . Pediatr Neurosurg2003;38:195—205.
39.
Karenfort M. , Kruse B., Freitag H., et al: Epilepsy surgery outcome in children with focal epilepsy due to tuberous sclerosis complex. Neuropediatrics2002;33:255—261.
40.
Vigliano P. , Canavese C., Bobba, B. et al: Transmantle dysplasia in tuberous sclerosis: Clinical features and surgical outcome in four children. J Child Neurol2002;17:752—758.
41.
Thiele EA, Duffy FH, Poussaint TY, et al: Intractable epilepsy and TSC: The role of epilepsy surgery in the pediatric population, abstract. J Child Neurol2001;16:681.
42.
Bebin EM, Kelly PJ, Gomez MR: Surgical treatment for epilepsy in cerebral tuberous sclerosis. Epilepsia1993;34:651—657.
43.
Acharya JN, Kotagal P., Dinner DS, et al: Surgical treatment of epilepsy in patients with tuberous sclerosis, abstract. TSC Millennium Symposium 2000 (September 13th—15th). Edinburgh, UK: TSC Millenium Research Symposium, 2000.
44.
Neville Bgr, Cross HC, Boyd SG, et al: Surgery for epilepsy in children with tuberous sclerosis, abstract . TSC Millennium Symposium 2000. (September 13th—15th) . Edinburgh, UK: TSC Millenium Research Symposium, 2000.
45.
Parain D., Penniello MJ, Berquen P., et al: Vagal nerve stimulation in tuberous sclerosis complex patients . Pediatr Neurol2001;25:213—216.
46.
Binnie CD: Vagus nerve stimulation for epilepsy: A review. Seizure2000;9:161—169.
47.
Avellino AM , Berger MS, Rostomily RC, et al: Surgical management and seizure outcome in patients with tuberous sclerosis. J Neurosurg1997;87:391—396.
48.
Koh S., Jayakar P., Dunoyer C., et al: Epilepsy surgery in children with tuberous sclerosis complex: Presurgical evaluation and outcome. Epilepsia2000;41:1206—1213.
